Medicina
Facultad
University of Regensburg
Ratisbona, AlemaniaPublicaciones en colaboración con investigadores/as de University of Regensburg (27)
2024
-
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE
Advances in Therapy, Vol. 41, Núm. 3, pp. 1103-1119
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, Núm. 4, pp. 353-370
-
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Bone Marrow Transplantation, Vol. 58, Núm. 10, pp. 1084-1088
2022
2021
-
A Family Affair: Addressing the Challenges of Factor H and the Related Proteins
Frontiers in Immunology, Vol. 12
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
European Journal of Immunology, Vol. 51, Núm. 12, pp. 2708-3145
2020
-
Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
Frontiers in Pediatrics, Vol. 8
-
Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)
European Urology
-
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†[Formula presented]: Under the Auspices of the EAU-ESMO Guidelines Committees
European Urology, Vol. 77, Núm. 2, pp. 223-250
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22
-
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Cardiac Failure Review, Vol. 6
2019
-
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Annals of Oncology, Vol. 30, Núm. 11, pp. 1697-1727
-
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Nature Communications, Vol. 10, Núm. 1
-
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Human Mutation, Vol. 40, Núm. 9, pp. 1557-1578
2018
-
Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups
European Journal of Surgical Oncology, Vol. 44, Núm. 9, pp. 1378-1383
-
Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study
European Journal of Surgical Oncology, Vol. 44, Núm. 11, pp. 1786-1792
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2016
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687